✦ LIBER ✦

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

✍ Scribed by Qing-Wei Ye; Margalit B. Mokyr; Joseph M. Pyle; Sheldon Dray

Publisher: Springer-Verlag
Year: 1984
Tongue: English
Weight: 928 KB
Volume: 16
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf00205423

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide-mediated enhancement of

Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

✍ Margalit B. Mokyr; Michael Colvin; Sheldon Dray 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 953 KB

Melphalan-mediated potentiation of antit

Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

✍ Robert C. Bocian; Shlomo Ben-Efraim; Sheldon Dray; Margalit B. Mokyr 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 927 KB

Administration of a low dose of L-PAM (0.75 mg/kg) to mice bearing a large SC MOPC-315 tumor and extensive metastases led to the development of augmented antitumor immune potential in their hitherto immunosuppressed spleen cells. Such drug-induced potentiation of antitumor immune responsiveness appe

Effect of low-dose cyclophosphamide ther

Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

✍ James A. Wise; Margalit B. Mokyr; Sheldon Dray 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 770 KB

Some T cell-dependent immune parameters were examined in mice bearing a large MOPC-315 plasmacytoma before and after treatment with a low dose (15 mg/kg) of CY. Prior to CY therapy, spleen cells from mice bearing a large MOPC-315 tumor were depressed in their ability to generate an in vitro cytotoxi

Some approaches to improve the therapeut

Some approaches to improve the therapeutic effectiveness of adoptive chemoimmunotherapy with spleen cells from melphalan-treated BALB/C mice bearing a large MOPC-315 tumor

✍ Larry M. Weiskirch; Margalit B. Mokyr 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 1020 KB

## Abstract Spleen cells from BALB/c mice that are in the process of eradicating a large MOPC‐315 tumor following low‐dose L‐PAM therapy (L‐PAM TuB spleen cells) were previously shown to be capable of bringing about the complete regression of a large (15 to 20 mm) s.c. MOPC‐315 tumor in a substanti

Suppression of immune response to sheep

Suppression of immune response to sheep red blood cells in mice treated with preparations of a tumor cell component and in tumor-bearing mice

✍ Mary A. Pikovski; Y. Ziffroni-Gallon; I. P. Witz 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 1 views

## Abstract The frequency of rosette‐forming cells (RFC) in spleens of mice immunized with sheep red blood cells (SRBC) was significantly reduced by pretreatment with preparations obtained from tumor extracts. This effect was not produced by preparations obtained by similar methods from normal tiss

Evolution of cell-mediated antitumor imm

Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells

✍ Jean Belehradek Jr.; Georges Barski; Monique Thonier 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 French ⚖ 732 KB

## Abstract The evolution of the specific cell‐mediated immune status was studied in C57BL/6 mice bearing a chemically induced syngeneic sarcoma, the TBL CL2 tumor. Peritoneal cells (PC) as the source of immunocompetent cells were repeatedly harvested from the same groups of mice checked in the in